Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Glutamatergic and GABAergic anteroventral BNST projections to PVN CRH neurons regulate maternal separation-induced visceral pain
    Published on 2023-07-29
    2 years ago
  • A unique role for cAMP signaling in microglia during opioid tolerance and withdrawal
    Published on 2023-07-28
    2 years ago
  • Effect of selective serotonin reuptake inhibitor treatment following diagnosis of depression on suicidal behaviour risk: a target trial emulation
    Published on 2023-07-28
    2 years ago
  • Correction: Ethical considerations in rapid and novel treatments in psychiatry
    Published on 2023-07-28
    2 years ago
  • Integrating public health and translational basic science to address challenges of xylazine adulteration of fentanyl
    Published on 2023-07-27
    2 years ago
  • Kynurenic acid: translational perspectives of a therapeutically targetable gliotransmitter
    Published on 2023-07-27
    2 years ago
  • Control of dopamine communication by opioids: glutamate enters the discussion
    Published on 2023-07-27
    2 years ago
« Previous 1 … 69 70 71 72 73 … 143 Next »
Journal of Psychopharmacology
  • The epidemiology of mescaline use: Pattern of use, motivations for consumption, and perceived consequences, benefits, and acute and enduring subjective effects
    Published on 2021-05-05
    4 years ago
  • Role of the norepinephrine transporter polymorphisms in atomoxetine treatment: From response to side effects in children with ADHD
    Published on 2021-05-04
    4 years ago
  • Challenges in translational research: MDMA in the laboratory versus therapeutic settings
    Published on 2021-05-04
    4 years ago
  • A prospective study to determine the clinical utility of pharmacogenetic testing of veterans with treatment-resistant depression
    Published on 2021-05-03
    4 years ago
  • Effect of medication on risk of traumatic brain injury in patients with bipolar disorder: A nationwide population-based cohort study
    Published on 2021-05-03
    4 years ago
  • Equasy revisited
    Published on 2021-05-03
    4 years ago
  • The biologically active compound of Withania somnifera (L.) Dunal, docosanyl ferulate, is endowed with potent anxiolytic properties but devoid of typical benzodiazepine-like side effects
    Published on 2021-05-03
    4 years ago
« Previous 1 … 69 70 71 72 73 … 124 Next »
European Neuropsychopharmacology
  • Guanosine boosts the fast, but not sustained, antidepressant-like and pro-synaptogenic effects of ketamine by stimulating mTORC1-driven signaling pathway
    Published on 2022-01-08
    4 years ago
  • Metabolomics changes after rTMS intervention reveal potential peripheral biomarkers in methamphetamine dependence
    Published on 2022-01-04
    4 years ago
  • When depression is difficult to treat
    Published on 2022-01-04
    4 years ago
  • Corrigendum to “Modelling decision-making under uncertainty: A direct comparison study between human and mouse gambling data” [31, February 2020, Pages  58–68]
    Published on 2021-12-22
    4 years ago
  • Corrigendum to “Chronic exposure to glucocorticoids induces suboptimal decision-making in mice” [Volume 46, May 2021, Pages 56-67]
    Published on 2021-12-22
    4 years ago
  • The polysemous concepts of psychomotricity and catatonia: A European multi-consensus perspective
    Published on 2021-12-21
    4 years ago
  • Influence of pre-treatment structural brain measures on effects of action-based cognitive remediation on executive function in partially or fully remitted patients with bipolar disorder
    Published on 2021-12-20
    4 years ago
« Previous 1 … 69 70 71 72 73 … 144 Next »

   Pharma Pub